Skip to content

Association of Postoperative Anaemia With Patient-centred Outcomes

Association of Postoperative Anaemia With Patient-centred Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04978285
Enrollment
3000
Registered
2021-07-27
Start date
2021-07-16
Completion date
2021-11-30
Last updated
2022-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia After Surgery

Keywords

anemia, complications, hemoglobin, iron, patient-centered outcome, surgery

Brief summary

Primary aim - To investigate the relationship between postoperative anaemia and patient-centred outcomes after major abdominal surgery. Secondary aim - To determine whether a more liberal perioperative IV fluid strategy increases the risk of postoperative anaemia (haemodilution). Hypothesis: Adults with anaemia in the immediate postoperative period following major abdominal surgery have a poorer quality of recovery and higher risk of complications, leading to poor disability-free survival when compared with patients without postoperative anaemia.

Detailed description

The consequences of postoperative anemia remain unclear. Postoperative anaemia is more likely if there is pre-existing anemia, but also increased perioperative blood loss, frequent blood sampling, excess IV fluids (leading to hemodilution), sepsis, and inadequate nutritional intake after surgery. A nadir in Hb concentration is most often observed within the first 3-4 days after surgery. Postoperative anemia is believed to have deleterious effects on patient outcomes, including prolonged hospital stay, increased postoperative complications, and perhaps poor survival, but there is very little data to support this belief. A recent consensus statement suggested that all patients recovering from major surgery (defined as blood loss \> 500 ml or lasting \> 2 h) and either had preoperative anemia or moderate-to-severe blood loss during surgery must be screened for anemia after surgery. Furthermore, this consensus group recommended that patients recovering from uncomplicated major surgery should have their Hb concentration measured for at least 3 days after surgery to detect anemia. As outlined above, this is problematic if there is fluid retention. The role of IV iron for the treatment of postoperative anemia is unclear, with the most recent systematic review concluding that neither oral nor IV iron had a significant effect on patient quality of life or functional outcomes following surgery. A diagnosis of iron deficiency is very difficult in the postoperative period because the acute phase inflammatory response results in spuriously elevated ferritin levels, and several studies have demonstrated oral iron therapy is ineffective in this setting. The investigators propose a study to investigate the incidence, extent, and outcomes of patients with anemia after major surgery, including an assessment of the amount of IV fluids administered in the immediate perioperative period.

Interventions

OTHERAnemia

Depends on Day 3 Hb result

Sponsors

Monash University
CollaboratorOTHER
Bayside Health
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults (≥18 years) undergoing elective major surgery and providing informed consent 2. All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days 3. At increased risk of postoperative complications, as defined by any of the following criteria: 1. age ≥70 years 2. known or documented history of coronary artery disease 3. known or documented history of heart failure 4. diabetes currently treated with an oral hypoglycemic agent and/or insulin 5. preoperative serum creatinine \>200 micromol/L (\>2.8 mg/dl) 6. morbid obesity (BMI ≥35 kg/m2) 7. preoperative serum albumin \<30 g/L 8. anaerobic threshold (if done) \<12 mL/kg/min 9. or two or more of the following risk factors: * ASA 3 or 4 * chronic respiratory disease * obesity (BMI 30-35 kg/m2) * aortic or peripheral vascular disease * preoperative Hb \<100 g/L * preoperative serum creatinine 150-199 micromol/L (\>1.7 mg/dl) * anerobic threshold (if done) 12-14 mL/kg/min

Exclusion criteria

1. Urgent or time-critical surgery 2. ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy) 3. Chronic renal failure requiring dialysis 4. Pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions 5. Liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation 6. Minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically minor surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.

Design outcomes

Primary

MeasureTime frameDescription
Persistent disability or death by 90 days90 days after surgeryDefined as a World Health Organization Disability Assessment Schedule 2.0 (WHODAS) score of at least 24 points (on the 48-point scale) at both 30 and 90 days postoperatively, reflecting a disability level of at least 25% and being the threshold point between disabled and not disabled as per WHO guidelines. Disability was assessed by the participant, but if unable then we used the proxy's report.

Secondary

MeasureTime frameDescription
A composite (pooled) and individual septic complications: sepsis, surgical site infection, anastomotic leak, and pneumonia30 days
Sepsis: using Centers for Disease Control and Prevention (CDC) with National Healthcare Safety Network (NHSN) criteria30 days
Surgical site infection30 daysCDC criteria
Pneumonia30 daysThe presence of new and/or progressive pulmonary infiltrates on chest radiograph plus two or more of the following: i. Fever ≥ 38.5°C or postoperative hypothermia \<36°C ii. Leucocytosis ≥ 12,000 WBC/mm3 or leucopenia \< 4,000 WBC/mm3 iii. Purulent sputum and/or iv. New onset or worsening cough or dyspnea.
Anastomotic leak30 daysA defect of the intestinal wall at the anastomotic site (including suture and staple lines of neorectal reservoirs) leading to a communication between the intra- an extra luminal compartments.
Death: all-cause mortality at 90 days, then up to 12 months after surgery1 year
Unplanned admission to ICU within 30 days of surgery30 days
ICU stay30 daysTotal days - additive, including initial ICU admission and readmission times up to Day 30
Hospital stay30 daysTotal -additive, from the start (date, time) of surgery until actual hospital discharge , plus readmission(s) up to Day 30
Quality of recoveryPostoperative Days 3 and 30QoR-15 scale score
Hospital re-admissionAt 3, 6 and 12 months.
Acute kidney injury30 daysAccording to The Kidney Disease: Improving Global Outcomes (KDIGO) group criteria, but not urine output - for Stage 2 or worse AKI defined as at least 2-fold increase in creatinine, or estimated GFR decrease \>50%

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026